Community connect

Connecting to Find Solutions Together

Caring for the person with pain today can be complicated. The prevalence of chronic pain combined with the abuse, misuse and illegal diversion of pain medications has created a complex public health crisis.1 Caring for the person with pain is a shared responsibility. To forge a productive path forward in addressing pain management issues, prescribers and pharmacists can connect with one another and work collaboratively to find solutions together. Understanding the various perspectives on the issues (prescriber, pharmacist and regulatory) sheds light on the importance of improving the process of effectively treating chronic pain in our communities.

Care in Our Communities

Community Connect is a program designed to foster improved healthcare provider collaboration and coordination of care for the person with pain by sharing various perspectives, best practices and simple tools for pharmacists and prescribers to consider implementing in their local communities.

Sharing Perspectives

Community Connect events implemented across the country in 2014 featured a panel of thought leaders on chronic pain management, outcomes and policy and U.S. Drug Enforcement Administration regulations. Audiences of local pharmacists and prescribers at the events generated engaging and interesting discussions focused on ways to improve and foster greater collaboration and communication in their communities.

Thought Leader Panel

Bob Twillman, PhD, FAPM

Deputy Executive Director and Director of Policy and Advocacy, American Academy of Pain Management
Chair of the Prescription Monitoring Program Advisory Committee, Kansas Board of Pharmacy

Bill McCarberg, MD

Founder of the Chronic Pain Management Program, Kaiser Permanente

David Brushwood, RPh, JD

Professor of Pharmaceutical Outcomes and Policy
Professor Emeritus, University of Florida College of Pharmacy

John Coleman, PhD

President, Prescription Drug Research Center
Former Assistant Administrator of Operations, Drug Enforcement Administration (DEA)

Community Connect Resources

Thought Leader Panel Discussion

In 2014, Community Connect events were implemented across the country. Watch this 20-minute Thought Leader Panel Discussion video to learn about the various perspectives regarding our nation’s public health crisis in pain management and hear best practices directly from our panel members.

An Advocacy & Policy Perspective
Remarks from: Program Chairperson Bob Twillman, PhD, FAPM

Deputy Executive Director and Director of Policy and Advocacy, American Academy of Pain Management
Chair of the Prescription Monitoring Program Advisory Committee, Kansas Board of Pharmacy

A Prescriber Perspective
Remarks from: Bill McCarberg, MD

Founder of the Chronic Pain Management Program, Kaiser Permanente

A Pharmacist Perspective
Remarks from: David Brushwood, RPh, JD

Professor of Pharmaceutical Outcomes and Policy
Professor Emeritus, University of Florida College of Pharmacy

A Regulatory Perspective
Remarks from: John Coleman, PhD

President, Prescription Drug Research Center
Former Assistant Administrator of Operations,
Drug Enforcement Administration (DEA)

Conducting a Local Community Connect Program

Though pain management is a national public health crisis, real solutions can be discussed and implemented on a community level. Whether you are an individual or group interested in planning a local event, there are many ideas and potential solutions that can be generated to help improve the process by bringing people together to talk about their various points of view.
Click to read more about coordinating your own local event and to access the event checklist.

References
  1. Gaskin DJ, Richard P. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Institute of Medicine of the National Academies. 2011;301-315. Accessed February 1, 2014.

Community Connect is a non-CME/CE educational event. The program content was developed by the American Academy of Pain Management and Janssen Pharmaceuticals, Inc. The speakers were paid consultants for Janssen Pharmaceuticals, Inc.